A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.
<h4>Background</h4>Pre-eclampsia/eclampsia are leading causes of maternal mortality and morbidity, particularly in low- and middle- income countries (LMICs). We developed the miniPIERS risk prediction model to provide a simple, evidence-based tool to identify pregnant women in LMICs at i...
Saved in:
| Main Authors: | Beth A Payne, Jennifer A Hutcheon, J Mark Ansermino, David R Hall, Zulfiqar A Bhutta, Shereen Z Bhutta, Christine Biryabarema, William A Grobman, Henk Groen, Farizah Haniff, Jing Li, Laura A Magee, Mario Merialdi, Annettee Nakimuli, Ziguang Qu, Rozina Sikandar, Nelson Sass, Diane Sawchuck, D Wilhelm Steyn, Mariana Widmer, Jian Zhou, Peter von Dadelszen, miniPIERS Study Working Group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1001589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MuSK is a substrate for CaMK2β but this interaction is dispensable for MuSK activation in vivo
by: Jakob J. Prömer, et al.
Published: (2025-04-01) -
Two-faced Janus SkQ1/SkQR1: patterns and molecular volume threshold for substrate recognition by the AcrAB-TolC pump
by: Marina V. Karakozova, et al.
Published: (2025-03-01) -
MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
by: Shalini Bhaskar, et al.
Published: (2022-01-01) -
Sequent calculus Sk4 for skolemized formulas
by: Andrejus Belovas, et al.
Published: (2005-12-01) -
Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
by: Jamie L. Lim, et al.
Published: (2025-02-01)